Ultivue Announces Relocation and Expansion for New Corporate Headquarters

Ultivue, Inc. announced the relocation and expansion of its corporate headquarters to a new office and laboratory facility in Burlington, MA to advance the operations and growth of the company. Avison Young’s Boston office arranged a new 56,000-square-foot lease on behalf of biotechnology company Ultivue at Burlington Biocenter. Ultivue will relocate and triple in size from its previous Cambridge location in the Fall of 2022.

February 9, 2022

Ultivue, a leader in advancing precision medicine and unique image analysis solutions by accelerating tissue biomarker discovery and validation develops unique assays for use in multiplex immunofluorescence imaging and analysis. Its proprietary InSituPlex® technology is designed for fast and comprehensive exploration of biologically relevant markers combined with same slide-H&E analysis in precious tissue samples.

“Ultivue’s move and significant expansion at Burlington Biocenter is a strong indication of the company’s continued growth and the unwavering demand from life sciences tenants in the market,” said Kevin Malloy. “Market conditions were extremely challenging during our search as a result of biotech tenants leasing space at record levels. We ultimately secured the ideal space for the company’s evolving laboratory and office needs.”

“Avison Young did an exceptional job strategically navigating a challenging market with limited inventory to procure a space that aligned with our research, development and growth needs,” said James (Bud) Drummey, Vice President of Product and Quality at Ultivue who lead the facility search efforts. “Burlington Biocenter’s cutting-edge, lab-ready facilities and prime suburban location provided the space and efficiency for us to maximize productivity while acquiring and retaining top talent.”

About Avison Young

Avison Young creates real economic, social and environmental value as a global real estate advisor, powered by people. As a private company, clients collaborate with an empowered partner who is invested in their success. Avison Young is a 2021 winner of the Canada’s Best Managed Companies Platinum Club designation, having retained its Best Managed designation for 10 consecutive years.
For more information, visit avisonyoung.com

About Ultivue

Ultivue provides pathologists, researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs. For more information, visit ultivue.com.

Avison Young

Kevin Malloy





James Drummey

Vice President of Product and Quality +1.617.250.7603   


Latest articles